Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Pediatrics
Published in: Indian Journal of Pediatrics 2/2015

01-02-2015 | Review Article

Neurocysticercosis

Authors: Pratibha Singhi, Renu Suthar

Published in: Indian Journal of Pediatrics | Issue 2/2015

Login to get access

Abstract

Neurocysticercosis is the commonest parasitic disease of the nervous system in humans, and constitutes a major public health problem for most of the developing world. The clinical manifestations of Neurocysticercosis (NCC) largely depend on number of lesions, site, and host immune response against the parasite. Diagnosis is mainly based upon neuro imaging studies and is supported by antibody/antigen detection in the serum and occasionally the cerebrospinal fluid. Randomized controlled trials evaluating the clinical benefit of treatment with cysticidal agents have shown hastened resolution of lesions in most, and reduced seizure recurrence in some studies. Outcome is favourable in single lesion parenchymal NCC but is guarded in multiple lesion and extra parenchymal NCC.
Literature
1.
Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, et al; Cysticercosis Working Group in Peru. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology. 2005;65:229–33.CrossRefPubMed
2.
Medina MT, Aguilar-Estrada RL, Alvarez A, Duron RM, Martinez L, Dubon S, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salama, Honduras study. Epilepsia. 2011;52:1177–85.CrossRefPubMed
3.
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4:e870.PubMedCentralCrossRefPubMed
4.
Prasad KN, Verma A, Srivastava S, Gupta RK, Pandey CM, Paliwal VK. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India. Trans R Soc Trop Med Hyg. 2011;105:531–6.CrossRefPubMed
5.
Raina SK, Razdan S, Pandita KK, Sharma R, Gupta VP, Razdan S. Active epilepsy as indicator of neurocysticercosis in rural northwest India. Epilepsy Res Treat. 2012;2012:802747.PubMedCentralPubMed
6.
Singh G, Bawa J, Chinna D, Chaudhary A, Saggar K, Modi M, et al. Association between epilepsy and cysticercosis and toxocariasis: a population-based case–control study in a slum in India. Epilepsia. 2012;53:2203–8.CrossRefPubMed
7.
8.
9.
10.
Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry. 1986;49:1131–4.PubMedCentralCrossRefPubMed
11.
Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonca R, et al. Ununsual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. Arq Neuro-psiquiatr. 2003;61:533–41.CrossRef
12.
Del Brutto OH. Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Pediatr Neurol. 2013;48:432–5.CrossRefPubMed
13.
Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol. 2000;15:207–13.CrossRefPubMed
14.
15.
Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol. 2011;53:600–9.CrossRefPubMed
16.
Talukdar B, Saxena A, Popli VK, Choudhury V. Neurocysticercosis in children: clinical characteristics and outcome. Ann Trop Paediatr. 2002;22:333–9.CrossRefPubMed
17.
18.
David S, Mathai E. Ocular cysticercosis–a review of 25 cases. J Assoc Physicians India. 2000;48:704–7.PubMed
19.
Nash T. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health. 2012;106:275–9.PubMedCentralCrossRefPubMed
20.
Lerner A, Shiroishi MS, Zee CS, Law M, Go JL. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2012;22:659–76.CrossRefPubMed
21.
de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K. Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging. Epilepsia. 2011;52:1918–27.CrossRefPubMed
22.
Ito A, Yamasaki H, Nakao M, Sako Y, Okamoto M, Sato MO, et al. Multiple genotypes of taenia solium–ramifications for diagnosis, treatment and control. Acta Trop. 2003;87:95–101.CrossRefPubMed
23.
Atluri SR, Singhi P, Khandelwal N, Malla N. Evaluation of excretory secretory and 10–30 kDa antigens of taenia solium cysticerci by EITB assay for the diagnosis of neurocysticercosis. Parasite Immunol. 2009;31:151–5.CrossRefPubMed
24.
25.
Atluri VS, Singhi PD, Khandelwal N, Malla N. 2D-PAGE analysis of taenia solium metacestode 10–30 kDa antigens for the serodiagnosis of neurocysticercosis in children. Acta Trop. 2011;118:165–9.CrossRefPubMed
26.
Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996;142:1–6.CrossRefPubMed
27.
Del Brutto OH, Rajshekhar V, White Jr AC, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177–83.PubMedCentralCrossRefPubMed
28.
Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg. 1993;78:402–7.CrossRefPubMed
29.
Pretell EJ, Martinot C Jr, Garcia HH, Alvarado M, Bustos JA, Martinot C, et al; Cysticercosis Working Group in Peru. Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Aassist Tomogr. 2005;29:112–4.
30.
Singhi PD, Baranwal AK. Single small enhancing computed tomographic lesions in indian children–II. clinical features, pathology, radiology and management. J Trop Pediatr. 2001;47:266–70.CrossRefPubMed
31.
Singhi PD, Dinakaran J, Khandelwal N. Singhi SC one vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr. 2003;49:274–8.CrossRefPubMed
32.
Sharma LN, Garg RK, Verma R, Singh MK, Malhotra HS. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation. Seizure. 2013;22:840–5.CrossRefPubMed
33.
Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev. 2010;3:CD000215.
34.
Otte WM, Singla M, Sander JW, Singh G. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology. 2013;80:152–62.PubMedCentralCrossRefPubMed
35.
Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the guideline development subcommittee of the American academy of neurology. Neurology. 2013;80:1424–9.PubMedCentralCrossRefPubMed
36.
Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J. 2009;28:403–6.CrossRefPubMed
37.
Sinha S, Sharma BS. Intraventricular neurocysticercosis: a review of current status and management issues. Br J Neurosurg. 2012;26:305–9.CrossRefPubMed
38.
Khade P, Lemos RS, Toussaint LG. What is the utility of postoperative antihelminthic therapy after resection for intraventricular neurocysticercosis? World Neurosurg. 2013;79:558–67.CrossRefPubMed
39.
Sikasunge CS, Johansen MV, Phiri IK, Willingham AL 3rd, Leifsson PS. The immune response in Taenia solium neurocysticercosis in pigs is associated with astrogliosis, axonal degeneration and altered blood–brain barrier permeability. Vet Parasitol. 2009;160:242–50.CrossRefPubMed
Metadata
Title
Neurocysticercosis
Authors
Pratibha Singhi
Renu Suthar
Publication date
01-02-2015
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 2/2015
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-014-1576-3

Other articles of this Issue 2/2015

Indian Journal of Pediatrics 2/2015 Go to the issue

Clinical Brief

Complete Bilateral Ophthalmoplegia with Unilateral Facial Palsy in a Child with Anti-GQ1b Syndrome

Editorial

Editorial: Advances in Neurology

Review Article

Advances in Pediatric Neuroimaging

Clinical Brief

Real Time PCR in Childhood Tuberculosis: A Valuable Diagnostic Tool

Scientific Letter

Spontaneously Disappearing Pineal Region Mass: A Rare Manifestation of Vein of Galen Malformation

Original Article

Comparison of Micronutrient Levels in Children with Cerebral Palsy and Neurologically Normal Controls